Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Statistics

Total Valuation

CRVS has a market cap or net worth of $666.91 million. The enterprise value is $601.67 million.

Market Cap	666.91M
Enterprise Value	601.67M

Important Dates

The last earnings date was Tuesday, November 4, 2025, after market close.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

CRVS has 74.68 million shares outstanding. The number of shares has increased by 34.14% in one year.

Current Share Class	74.68M
Shares Outstanding	74.68M
Shares Change (YoY)	+34.14%
Shares Change (QoQ)	+6.51%
Owned by Insiders (%)	3.95%
Owned by Institutions (%)	38.85%
Float	58.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	9.27
P/TBV Ratio	9.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.29, with a Debt / Equity ratio of 0.01.

Current Ratio	8.29
Quick Ratio	8.18
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -35.82% and return on invested capital (ROIC) is -56.78%.

Return on Equity (ROE)	-35.82%
Return on Assets (ROA)	-34.87%
Return on Invested Capital (ROIC)	-56.78%
Return on Capital Employed (ROCE)	-53.67%
Revenue Per Employee	n/a
Profits Per Employee	-$486,290
Employee Count	31
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.94% in the last 52 weeks. The beta is 0.64, so CRVS's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+8.94%
50-Day Moving Average	7.20
200-Day Moving Average	4.95
Relative Strength Index (RSI)	69.32
Average Volume (20 Days)	1,048,063

Short Selling Information

The latest short interest is 9.03 million, so 12.09% of the outstanding shares have been sold short.

Short Interest	9.03M
Short Previous Month	8.83M
Short % of Shares Out	12.09%
Short % of Float	15.54%
Short Ratio (days to cover)	8.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.86M
Pretax Income	-15.08M
Net Income	-15.08M
EBITDA	-38.76M
EBIT	-38.86M
Earnings Per Share (EPS)	-$0.56

Balance Sheet

The company has $65.69 million in cash and $1.01 million in debt, giving a net cash position of $64.68 million or $0.87 per share.

Cash & Cash Equivalents	65.69M
Total Debt	1.01M
Net Cash	64.68M
Net Cash Per Share	$0.87
Equity (Book Value)	71.77M
Book Value Per Share	0.96
Working Capital	58.87M

Cash Flow

In the last 12 months, operating cash flow was -$32.07 million and capital expenditures -$149,000, giving a free cash flow of -$32.22 million.

Operating Cash Flow	-32.07M
Capital Expenditures	-149,000
Free Cash Flow	-32.22M
FCF Per Share	-$0.43

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.14%
Shareholder Yield	-34.14%
Earnings Yield	-2.26%
FCF Yield	-4.84%

Analyst Forecast

The average price target for CRVS is $13.75, which is 53.98% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.75
Price Target Difference	53.98%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1